HOME >> BIOLOGY >> NEWS
Salmonella Vaccine Now Available For Poultry

A vaccine invented by a biologist at Washington University in St. Louis has received federal approval for use in controlling Salmonella bacteria in poultry.

Megan Health Inc., a St. Louis based vaccine discovery company, has been granted a United States Department of Agriculture (USDA) license for a vaccine that controls Salmonella contamination of poultry products.

The new vaccine, Megan™Vac 1, is applied to baby chicks via spray in the hatchery. The vaccine stimulates immunity in the chickens, preventing Salmonella infection during the growing period which may result in contamination and subsequent food borne infection of humans.

In recently completed trials on US commercial broiler farms which included more than a million pounds of chicken, Megan™Vac 1 eliminated Salmonella on dressed chicken. Ten percent of the non-vaccinated chickens in these trials were contaminated.

The US broiler chicken industry has improved their processed chicken contamination rate greatly in the past few years moving from 50% positive in the 1980's to 20% positive two years ago to 10% this past year (according to tests reported by USDA's Food Safety Inspection Service). " Our new vaccine is a remarkable tool which will help broiler producers reach their goal of 0 % contamination." says David Zacek, President of Megan Health Animal Health Division.

The new vaccine, more than 4.5 years in development, is the invention of Roy Curtiss III, Ph.D., professor of biology at Washington University and founder of Megan Health, Inc.

"This vaccine is designed to live only long enough to stimulate an immune response in chickens and then is eliminated by the chickens' immune system to assure food safety at processing. It is very specific for Salmonella control, very low cost at less than one cent per bird and is easily applied using traditional techniques now used by US broiler chicken production companies." according to Sandra Kelly, MS, Biologicals Deve
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
3-Dec-1998


Page: 1 2

Related biology news :

1. Salmonella infects cells and saves itself by altering host membrane lipids
2. Salmonella uses molecular staples to change structure of infected cells
3. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
4. Researchers Identify Key Gene That Controls Emergence Of Salmonella
5. DT104 Advice:How To Slow Salmonella Spread
6. First Salmonella Vaccine For Poultry To Be On The Market Soon
7. Hope Clinic of Emory Vaccine Center receives CDC contract
8. Vaccines against foodborne disease on horizon
9. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
10. Vaccine technique shows potential against common form of lung cancer
11. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... ... June 22, 2017 , ... The first human cell ... years until the first data on cross-contamination of human cell lines with HeLa cells ... increasing issue in cell culture labs and is associated with dramatic consequences for research. ...
(Date:6/20/2017)... ... June 20, 2017 , ... CTNext , ... directors has formed a Higher Education Entrepreneurship Advisory Committee to implement the recommendations ... and other high-ranking representatives from 35 higher education institutions across the state over ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadyl™, the ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... antibody therapeutics from millions-diverse immune repertoires, announces launch of its new Surge(TM) ... Dave Johnson, PhD, CEO of GigaGen, will present on Surge at the conference. ...
Breaking Biology Technology:
Cached News: